OnKure Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.

OnKure Therapeutics, Inc. Class A

OnKure Therapeutics, Inc. Class A

OKUR

0.00

OnKure Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.